AktharS.S.: A 10-year experience of tamoxifen as primary treatment of breast cancer in 100 elderly and frail patients. Eur J Surg Oncol, 17: 30–35, 1991.
2.
BatesT.: Breast cancer in elderly women: a cancer research campaign trial comparing treatment with tamoxifen and optimal surgery with tamoxifen alone. Br J Surg, 78: 591–594, 1991.
3.
BradbeerJ., KyngdonJ.: Primary treatment of breast cancer in elderly women with tamoxifen. Clin Oncol, 9: 31–34, 1983.
4.
ForrestA.P.M.: Tamoxifen and mastectomy for elderly patients with operable breast cancer. BMJ, 297: 917–918, 1988.
5.
GazetJ.C.: Prospective randomized trial of Tamoxifen versus Surgery in elderly patients with breast cancer. Eur J Surg Oncol, 20: 207–214, 1994.
6.
HaagensenC.D.: The frequency and age distribution of mammary carcinoma. In SaundersWB (ed), Diseases of the breast (2nd edition): 348–353, 1971.
7.
HellebergA.: Treatment of localised breast cancer in elderly patients by tamoxifen. Br Rad, 55: 511–515, 1982.
8.
HorobinJ.M.: Long term follow-up of elderly patients with locoregional breast cancer treated with tamoxifen only. Br J Surg, 78: 213–217, 1991.
9.
HutchinsL.F.: Underrepresentation of patients 65 years of age or older in cancer-treatment trials. N Engl J Med, 341: 2061–2067, 1999.
10.
MustacchiG.: Tamoxifen or Surgery plus Tamoxifen as primary treatment for elderly patients with operable breast cancer: the GRETA Trial. Anticancer Res, 14: 2197–2200, 1994.
11.
National Cancer Institute: SEER cancer incidence public use database, 1973-1998 review.Bethesda, MD, US Department of health and human services, public health service, 2000.
12.
RobertsonJ.F.R.: Comparison of mastectomy with tamoxifen for tretaing elderly patients with operable breast cancer. BMJ, 297: 511–514, 1988.
